首页 | 本学科首页   官方微博 | 高级检索  
检索        

大剂量氨甲喋呤並醛氢叶酸救援疗法的临床观察——102例报告
引用本文:喻丽华,管忠震,赵香兰.大剂量氨甲喋呤並醛氢叶酸救援疗法的临床观察——102例报告[J].癌症,1991(6).
作者姓名:喻丽华  管忠震  赵香兰
作者单位:中山医科大学附属肿瘤医院内科,中山医科大学附属肿瘤医院内科,中山医科大学临床药理教研室 广州 510060,广州 510060,广州 510089
摘    要:本文报告HDMTXCFR救援疗法治疗骨肉瘤、非何杰金氏淋巴瘤等102例的临床观察,包括血药浓度监测及治疗结果。病例均经病理学确诊;共用HDMTXCFR307疗程;MTX剂量>1g/m~2者188例次(占61.2%)。63疗程进行了血药浓度监测。本组资料提示HDMTXCFR对骨肉瘤及非何杰金氏淋巴瘤中枢神经系统侵犯有一定疗效;只要注意水化,尿硷化及CF救援,此疗法是安全的。

关 键 词:氨甲喋呤  骨肉瘤  淋巴瘤  临床观察

CLINICAL OBSERVATION ON 102 CASES OF HIGH DOSE METH-OTREXATE CITROVORUM FACTOR RESCUE
YU Li-hua GUAN Zhong-zhen.CLINICAL OBSERVATION ON 102 CASES OF HIGH DOSE METH-OTREXATE CITROVORUM FACTOR RESCUE[J].Chinese Journal of Cancer,1991(6).
Authors:YU Li-hua GUAN Zhong-zhen
Abstract:102 cases of malignances, all pathohistologically comfirned, were treated with high does methotrexate/citrovorum factor rescue regimen (HDMTX-CFR) were reported.Of 307 cycles of HDMTX-CFR totally used, 188 cycles(61.2%) administered greates than. Ig/M 2 dose of MTX. MTX blood concentration was monitored by microbiological assay during the treatment of 63 cycles.We concluded that HDMTX-CFR is effective for osteosarcoma and central nervous system involvement of non-Hodgkin's lymphoma, and can be used safely under serum MTX concentration monitoring and careful clinical observation.
Keywords:High Dose Methotrexate/Citrovorum rescue  Osteosarcoma non-Hodg- kin's lymphoma  Clinical observation  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号